Redeye initiates coverage of Lifecare
2023-06-29 08:02:00
Redeye initiates coverage of Lifecare, an innovative medtech company offering a next-generation continuous glucose monitor sensor. We see it offering a robust value proposition targeting a multiple billion USD market growing by c15% annually and believe this could represent an ample growth story in the making.
Read more and download the Research Report.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/